Biobank Equipment Market to Reach USD 6.74 Billion by 2031 Driven by Genomics and AI-Powered Sample Management

[Boston, 29 July 2025] – The global biobank equipment market is expected to grow from USD 3.43 billion in 2024 to USD 6.74 billion by 2031, at a CAGR of 9.8%, according to Clearview Market Insights (CVMI). The growth is driven by national biobank programs, increased genomics research, and rising automation needs in sample processing and storage.
Request Sample: https://clearviewmarketinsights.com/report-details/global-biobank-equipment-market/
“Biobanks are the data engines of future medicine. Advanced equipment is crucial for quality storage, traceability, and throughput,” stated Dr. Nathan Jansen, Lead Life Sciences Analyst at CVMI.
Thermo Fisher Scientific, PHC Holdings, Hamilton, and Brooks Life Sciences lead the market with innovations in IoT-enabled cryogenic systems and blockchain-powered tracking tools. Academic institutions remain the largest buyers, but pharma and hospital networks are rapidly catching up.
Recent developments such as smart freezers with predictive maintenance, AI-linked sample handlers, and low-energy refrigeration systems are transforming laboratory workflows. The market also experiences robust regional growth in Asia-Pacific driven by expanding genomics and cancer registries.
For more insights, visit https://clearviewmarketinsights.com/
About Clearview Market Insights:
Clearview Market Insights is a leading market research and consulting firm providing in-depth industry analysis and strategic recommendations for businesses worldwide.
Media contact:
Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369